Back
Day Range
$4.14
$4.50
52-Week Range
$2.28
$4.59
Volume
600
50D / 200D Avg
$4.44
/
$3.49
Prev Close
$4.44
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -3.4 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.8 |
| Net Margin % | -1251.1 | 3.9 |
| Rev Growth 5Y % | 150.8 | 10.0 |
| D/E | — | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
-$0.11
-$0.11 – -$0.11
|
260 M | 4 |
| FY2028 |
-$0.55
-$0.55 – -$0.55
|
96 M | 3 |
| FY2027 |
-$0.67
-$0.67 – -$0.67
|
25 M | 2 |
Key Takeaways
Revenue grew 150.82% annually over 5 years — strong growth
Negative free cash flow of -86.26M
Revenue growth is decelerating — 1Y growth trails 5Y average by 166.57%
Capital efficient — spends only 2.26% of revenue on capex
Growth
Revenue Growth (5Y)
150.82%
Revenue (1Y)-15.75%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net Margin-1251.10%
Op. Margin-662.58%
Safety
Debt / Equity
N/A
Current Ratio0.92
Interest Coverage-8.01
Valuation
P/E Ratio
-3.35
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -15.75% | Revenue Growth (3Y) | 9.95% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 150.82% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 14.72M | Net Income (TTM) | -184.21M |
| ROE | N/A | ROA | -154.84% |
| Gross Margin | 62.47% | Operating Margin | -662.58% |
| Net Margin | -1251.10% | Free Cash Flow (TTM) | -86.26M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.92 |
| Interest Coverage | -8.01 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -3.35 | P/B Ratio | N/A |
| P/S Ratio | 41.93 | PEG Ratio | -0.04 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 617.43M | Enterprise Value | 575.20M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 14.72M | 17.48M | 12.18M | 4.19M | 372,000.0 |
| Net Income | -184.21M | -110.43M | -54.27M | -49.64M | -31.62M |
| EPS (Diluted) | -3.08 | -2.43 | -1.31 | -1.27 | -0.93 |
| Gross Profit | 9.20M | 17.50M | 11.18M | 3.18M | -474,000.0 |
| Operating Income | -97.56M | -102.71M | -57.11M | -52.11M | -29.72M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 118.97M | 69.56M | 116.00M | 121.99M | 138.92M |
| Total Liabilities | 225.61M | 101.59M | 70.53M | 33.12M | 27.71M |
| Shareholders' Equity | -106.65M | -32.03M | 45.48M | 88.87M | 111.21M |
| Total Debt | 54.33M | 37.49M | 34.51M | 10.12M | 13.25M |
| Cash & Equivalents | 96.56M | 26.92M | 86.74M | 86.55M | 105.69M |
| Current Assets | 111.51M | 48.19M | 106.38M | 115.58M | 133.00M |
| Current Liabilities | 120.73M | 50.16M | 30.70M | 22.85M | 13.91M |